Form D · Biotechnology
HYDRA BIOSCIENCES, LLC
Belmont, MA · CIK 0001172888
Offering snapshot reported Jun 11, 2019 · SEC filing
- Reported sold
- $1 Offering amount: $1
- Investors reported
- 97 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2019 | Initial | $1 | No comparison | 97 | SEC filing |
| Mar 31, 2015 | Initial | $10,507,500 | No comparison | 7 | SEC filing |
| Jan 21, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-341590
Source: Form D, filed Jun 11, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tom Burke | Executive |
| Robert Carpenter | Director |
| Bert Chenard, Ph.D. | Executive |
| Jean George | Director |
| Paul Goldenheim | Director |
| Steven Hall | Director |
| Russell Herndon | Director, Executive |
| Vincent Miles | Director |
| Magdalene Moran, Ph.D. | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
405 Concord Avenue #147
Belmont, MA, 02478
Belmont, MA, 02478